propofol has been researched along with Hallervorden-Spatz Disease in 2 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hurtado, P | 1 |
| Salvador, L | 1 |
| Carrero, E | 1 |
| Rumia, J | 1 |
| Fàbregas, N | 1 |
| Bujok, G | 1 |
| Misiołek, H | 1 |
2 other studies available for propofol and Hallervorden-Spatz Disease
| Article | Year |
|---|---|
[Anesthesia considerations for deep-brain stimulation in a patient with type-2 pantothenate kinase deficiency (Hallervorden-Spatz disease)].
Topics: Adult; Androstanols; Anesthesia, Intravenous; Deep Brain Stimulation; Dystonic Disorders; Female; Gl | 2009 |
[The choice of anesthesia in Hallervorden-Spatz disease].
Topics: Adult; Anesthetics, Intravenous; Female; Hemodynamics; Humans; Pantothenate Kinase-Associated Neurod | 2005 |